Methotrexate for the treatment of early diffuse scleroderma: comment on the article by Pope et al.
Lehman
Thomas J A
TJ
D018501:Antirheumatic Agents / Q000627:therapeutic use*; D002675:Child, Preschool; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use*; D012595:Scleroderma, Systemic / Q000188:drug therapy*
D018501:Antirheumatic Agents; D008727:Methotrexate